Occult bacteremia in living donor liver transplantation: a prospective observational study of recipients and donors.

Bacterial translocation Dysbiosis Predominant obligate anaerobe Ribosomal RNA-targeted RT-qPCR

Journal

Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360

Informations de publication

Date de publication:
10 Dec 2023
Historique:
received: 12 06 2023
accepted: 01 10 2023
medline: 11 12 2023
pubmed: 11 12 2023
entrez: 10 12 2023
Statut: aheadofprint

Résumé

To investigate the incidence and clinical impact of occult bacteremia in liver transplantation (LT). This prospective observational study involved a fixed-point observation for up to 2 weeks after living donor LT in 20 recipients, with 20 donors as comparison subjects. Bacteria in the blood samples were detected using the ribosomal RNA-targeted reverse-transcription quantitative polymerase chain reaction method. To identify the causality with the gut microbiota (GM), fecal samples were collected and analyzed simultaneously. Occult bacteremia was identified in four recipients (20%) and three donors (15%) before the operation, and in seven recipients (35%) and five donors (25%) after the operation. Clostridium leptum subgroup, Prevotella, Colinesella, Enterobacteriaceae, and Streptococcus were the main pathogens responsible. Although it did not negatively affect the donor post-hepatectomy outcomes, the recipients with occult bacteremia had a higher rate of infectious complications post-LT. The GM analyses showed fewer post-LT predominant obligate anaerobes in both the recipients and donors with occult bacteremia. Occult bacteremia is a common condition that occurs in both donors and recipients. While occult bacteremia generally remains subclinical in the healthy population, there is potential risk of the development of an apparent post-LT infection in recipients who are highly immunosuppressed.

Identifiants

pubmed: 38072872
doi: 10.1007/s00595-023-02778-7
pii: 10.1007/s00595-023-02778-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 18K08567

Informations de copyright

© 2023. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.

Références

Yokoyama Y, Fukaya M, Mizuno T, Ebata T, Asahara T, Nagino M. Clinical importance of “occult-bacterial translocation” in patients undergoing highly invasive gastrointestinal surgery: a review. Surg Today. 2021;51:485–92.
doi: 10.1007/s00595-020-02126-z pubmed: 32857253
Mizuno T, Yokoyama Y, Nishio H, Ebata T, Sugawara G, Asahara T, et al. Intraoperative bacterial translocation detected by bacterium-specific ribosomal rna-targeted reverse-transcriptase polymerase chain reaction for the mesenteric lymph node strongly predicts postoperative infectious complications after major hepatectomy for biliary malignancies. Ann Surg. 2010;252:1013–9.
doi: 10.1097/SLA.0b013e3181f3f355 pubmed: 21107112
Yokoyama Y, Nishigaki E, Abe T, Fukaya M, Asahara T, Nomoto K, et al. Randomized clinical trial of the effect of perioperative synbiotics versus no synbiotics on bacterial translocation after oesophagectomy. Br J Surg. 2014;101:189–99.
doi: 10.1002/bjs.9385 pubmed: 24402842
Fukaya M, Yokoyama Y, Usui H, Fujieda H, Sakatoku Y, Takahashi T, et al. Impact of synbiotics treatment on bacteremia induced during neoadjuvant chemotherapy for esophageal cancer: a randomised controlled trial. Clin Nutr. 2021;40:5781–91.
doi: 10.1016/j.clnu.2021.10.004 pubmed: 34775221
Søby JH, Watt SK, Vogelsang RP, Servant F, Lelouvier B, Raskov H, et al. Alterations in blood microbiota after colonic cancer surgery. BJS Open. 2020;4:1227–37.
doi: 10.1002/bjs5.50357 pubmed: 33022149 pmcid: 7709364
Mutignani M, Penagini R, Gargari G, Guglielmetti S, Cintolo M, Airoldi A, et al. Blood bacterial DNA load and profiling differ in colorectal cancer patients compared to tumor-free controls. Cancers (Basel). 2021;13:6363.
doi: 10.3390/cancers13246363 pubmed: 34944982
Sakaguchi S, Saito M, Tsuji H, Asahara T, Takata O, Fujimura J, et al. Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia. J Clin Microbiol. 2010;48:1624–8.
doi: 10.1128/JCM.01724-09 pubmed: 20351213 pmcid: 2863901
Coburn B, Morris AM, Tomlinson G, Detsky AS. Does this adult patient with suspected bacteremia require blood cultures? JAMA. 2012;308:502–11.
doi: 10.1001/jama.2012.8262 pubmed: 22851117
Niikura M, Atobe S, Takahashi A, Kado Y, Sugimoto T, Tsuji H, et al. Development of a rapid and sensitive analytical system for. Emerg Microbes Infect. 2021;10:677–86.
doi: 10.1080/22221751.2021.1906164 pubmed: 33734032 pmcid: 8023615
Suenaga M, Yokoyama Y, Fujii T, Yamada S, Yamaguchi J, Hayashi M, et al. Impact of preoperative occult-bacterial translocation on surgical site infection in patients undergoing pancreatoduodenectomy. J Am Coll Surg. 2021;232:298–306.
doi: 10.1016/j.jamcollsurg.2020.12.001 pubmed: 33316423
Iida T, Kaido T, Yagi S, Yoshizawa A, Hata K, Mizumoto M, et al. Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl. 2010;16:1379–85.
doi: 10.1002/lt.22165 pubmed: 21117247
Yao S, Yagi S, Uozumi R, Iida T, Nagao M, Okamura Y, et al. A high portal venous pressure gradient increases gut-related bacteremia and consequent early mortality after living donor liver transplantation. Transplantation. 2018;102:623–31.
doi: 10.1097/TP.0000000000002047 pubmed: 29319622
Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72:558–77.
doi: 10.1016/j.jhep.2019.10.003 pubmed: 31622696
Kaido T, Ogawa K, Mori A, Fujimoto Y, Ito T, Tomiyama K, et al. Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma. Surgery. 2013;154:1053–60.
doi: 10.1016/j.surg.2013.04.056 pubmed: 24074704
Alpern ER, Alessandrini EA, Bell LM, Shaw KN, McGowan KL. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics. 2000;106:505–11.
doi: 10.1542/peds.106.3.505 pubmed: 10969095
Yao S, Yagi S. Analyses focused on organisms would enhance the value of detecting occult bacteremia. J Am Coll Surg. 2021;233:161–2.
doi: 10.1016/j.jamcollsurg.2021.03.031 pubmed: 33867218
Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H, et al. Gut dysbiosis and detection of “live gut bacteria” in blood of Japanese patients with type 2 diabetes. Diabetes Care. 2014;37:2343–50.
doi: 10.2337/dc13-2817 pubmed: 24824547
Nishigaki E, Abe T, Yokoyama Y, Fukaya M, Asahara T, Nomoto K, et al. The detection of intraoperative bacterial translocation in the mesenteric lymph nodes is useful in predicting patients at high risk for postoperative infectious complications after esophagectomy. Ann Surg. 2014;259:477–84.
doi: 10.1097/SLA.0b013e31828e39e8 pubmed: 23549427
Yao S, Yagi S, Ogawa E, Hirata M, Miyachi Y, Iwamura S, et al. Dysbiosis and depletion of fecal organic acids correlate with the severity of rejection after rat liver transplantation. Transpl Int. 2022;35:10728.
doi: 10.3389/ti.2022.10728 pubmed: 36187462 pmcid: 9519788
Yao S, Yagi S, Hirata M, Miyachi Y, Ogawa E, Uozumi R, et al. Chronological changes in the gut microbiota and intestinal environment in recipients and donors of living donor liver transplantation. J Hepatobiliary Pancreat Sci. 2023;30:439–52.
doi: 10.1002/jhbp.1241 pubmed: 36178211
Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68:1516–26.
doi: 10.1136/gutjnl-2019-318427 pubmed: 31076401
Lakbar I, Einav S, Lalevée N, Martin-Loeches I, Pastene B, Leone M. Interactions between gender and sepsis-implications for the future. Microorganisms. 2023;11:746.
doi: 10.3390/microorganisms11030746 pubmed: 36985319 pmcid: 10058943
Bang CS, Yoon JH, Kim YJ, Kim JB, Baik GH, Suk KT, et al. Clinical impact of body mass index on bactibilia and bacteremia. BMC Gastroenterol. 2014;14:104.
doi: 10.1186/1471-230X-14-104 pubmed: 24902609 pmcid: 4073193
Pepper DJ, Demirkale CY, Sun J, Rhee C, Fram D, Eichacker P, et al. Does obesity protect against death in sepsis? A retrospective cohort study of 55,038 adult patients. Crit Care Med. 2019;47:643–50.
doi: 10.1097/CCM.0000000000003692 pubmed: 30789403 pmcid: 6465121
Lebovitz S, Rozen G, Abu Ghosh Z, Korem M, Elinav H, Zayyad H, et al. The relationship between body mass index and in-hospital mortality in bacteremic sepsis. J Clin Med. 2023;12:3848.
doi: 10.3390/jcm12113848 pubmed: 37298043 pmcid: 10253877
Asahara T, Takahashi A, Yuki N, Kaji R, Takahashi T, Nomoto K. Protective effect of a synbiotic against multidrug-resistant acinetobacter baumannii in a murine infection model. Antimicrob Agents Chemother. 2016;60:3041–50.
doi: 10.1128/AAC.02928-15 pubmed: 26953197 pmcid: 4862511
Asahara T, Shimizu K, Takada T, Kado S, Yuki N, Morotomi M, et al. Protective effect of Lactobacillus casei strain Shirota against lethal infection with multi-drug resistant Salmonella enterica serovar Typhimurium DT104 in mice. J Appl Microbiol. 2011;110:163–73.
doi: 10.1111/j.1365-2672.2010.04884.x pubmed: 21059159
Feng Y, Wang Y, Wang P, Huang Y, Wang F. Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy. Cell Physiol Biochem. 2018;49:190–205.
doi: 10.1159/000492853 pubmed: 30138914
Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341:569–73.
doi: 10.1126/science.1241165 pubmed: 23828891
Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65–80.
doi: 10.1053/j.gastro.2008.10.080 pubmed: 19026645
Stavrou G, Kotzampassi K. Gut microbiome, surgical complications and probiotics. Ann Gastroenterol. 2017;30:45–53.
pubmed: 28042237
Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569:655–62.
doi: 10.1038/s41586-019-1237-9 pubmed: 31142855 pmcid: 6650278

Auteurs

Siyuan Yao (S)

Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. siyuan@kuhp.kyoto-u.ac.jp.
The Dumont-UCLA Transplantation Center, Department of Surgery, Division of Liver and Pancreas Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, USA. siyuan@kuhp.kyoto-u.ac.jp.

Shintaro Yagi (S)

Department of Surgery, Graduate School of Medicine, Kanazawa University, Kanazawa, Ishikawa, Japan.

Takuya Sugimoto (T)

Yakult Central Institute, Yakult Honsha Co. Ltd., Tokyo, Japan.

Takashi Asahara (T)

Yakult Central Institute, Yakult Honsha Co. Ltd., Tokyo, Japan.

Shinji Uemoto (S)

Shiga University of Medical Science, Otsu, Shiga, Japan.

Etsuro Hatano (E)

Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Classifications MeSH